» Articles » PMID: 24145932

Characterization of the ABCC8 Gene Mutation and Phenotype in Patients with Congenital Hyperinsulinism in Western Saudi Arabia

Overview
Journal Saudi Med J
Specialty General Medicine
Date 2013 Oct 23
PMID 24145932
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To understand the genetic etiologies of congenital hyperinsulinism (CHI) in a population of Saudi patients, and to explore genotype-phenotype characteristics.

Methods: We retrospectively reviewed a cohort of 11 children with CHI presenting to King Abdulaziz University Hospital, Jeddah, Kingdom of Saudi Arabia between March 2007 and February 2012. Mutational analysis (ABCC8 and KCNJ11) was performed retrospectively to identify phenotype and genotype characteristics.

Results: Analysis revealed ABCC8 mutations in 81.8% (9/11) of patients, with 2 patients not revealing any gene mutation. All positive patients showed a homozygous mutation in the ABCC8 gene, one in exon 29, 2 in exon 1-22, 2 in exon 28, and 4 in intron 36; one patient had a heterozygous mutation. Five patients (45.4%) responded well to treatment with diazoxide not requiring subtotal pancreatectomy, while 6 patients (54.6%) required subtotal pancreatectomy despite treatment with diazoxide and octreotide. Three patients (33.3%) died while waiting for surgery due to sepsis and thrombosis. Two patients (18.1%) showed remission, one of them after subtotal pancreatectomy.

Conclusion: Homozygous mutations in ABCC8 are the most common causes of CHI in Saudi patients. Early diagnosis and therapy for persistent hyperinsulinemic hypoglycemia of infancy are essential to prevent neurodevelopmental delay.

Citing Articles

Large copy number variants are an important cause of congenital hyperinsulinism that should be screened for during routine testing.

Flanagan S, Lazaridi I, Mannisto J, Bennett J, Kalyon O, Johnson M Front Endocrinol (Lausanne). 2025; 16:1514916.

PMID: 40041288 PMC: 11876054. DOI: 10.3389/fendo.2025.1514916.


Incidence, predictors and outcomes of redo pancreatectomy in infants with congenital hyperinsulinism: a 16-year tertiary center experience.

Al-Ameer A, Alsomali A, Habib Z Pediatr Surg Int. 2023; 39(1):183.

PMID: 37079145 DOI: 10.1007/s00383-023-05470-6.


Clinical and genetic characteristics of patients with congenital hyperinsulinism in 21 non-consanguineous families from Serbia.

Raicevic M, Milenkovic T, Hussain K, Djordjevic M, Martic J, Todorovic S Eur J Pediatr. 2021; 180(9):2815-2821.

PMID: 33770274 DOI: 10.1007/s00431-021-04051-w.


Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Haris B, Saraswathi S, Hussain K Ther Adv Endocrinol Metab. 2020; 11:2042018820965068.

PMID: 33329885 PMC: 7720331. DOI: 10.1177/2042018820965068.


Enhanced Islet Cell Nucleomegaly Defines Diffuse Congenital Hyperinsulinism in Infancy but Not Other Forms of the Disease.

Han B, Newbould M, Batra G, Cheesman E, Craigie R, Mohamed Z Am J Clin Pathol. 2016; 145(6):757-68.

PMID: 27334808 PMC: 4922485. DOI: 10.1093/ajcp/aqw075.